Show Search Form
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answers by Lord Darzi of Denham on 22 July 2008 (HL4926 and HL4927) and by Earl Howe on 9 July 2012 (HL1211), of how many cycles the Human Fertilisation and Embryology Authority are aware in which fresh embryo transfers took place after 15 or more eggs were collected over each of the past ten years. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL2287 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government what assessment they have made of the risks of clinical trials of mitochondrial replacement therapy; and what safeguards will be put in place in such trials. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL1962 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government what assessment they have made of the role played by mitochondria in the development of an organism; and what they consider to be the implications of that assessment for mitochondrial replacement techniques. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL1963 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 24 July (HL1011), what is the proposed timetable of steps in deciding when mitochondrial donation should be offered in treatment; and what impact each of the separate experiments recommended by the Human Fertilisation and Embryology Authority’s Expert Panel will have on that timetable. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL1761 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 29 August 2013 (WA 315–16) and 24 January 2014 (WA 170–71), what progress the Human Fertilisation and Embryology Authority (HFEA) has made over the past year in implementing its action plan in response to the McCracken Report recommendations; what were the detailed policy outcomes of discussions between the Executive and Authority members described in paragraph 6.18 of the Minutes of the HFEA’s meeting on 11 September 2013; and what specific changes the HFEA has introduced to mitigate the risks of ovarian hyperstimulation syndrome in accordance with Recommendations 10 and 11 of the McCracken Report and in the light of paragraphs 4.40 and 4.44 therein. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL1092 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 9 July (WA 49), whether they consider that the inability of three reviews to find evidence to suggest any of the techniques evaluated are unsafe constitutes evidence that such techniques are safe; and if so, what is the purpose of the recommended experiments that should be completed before the techniques could be used in clinical practice. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL1011 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|